Checkpoint Capital’s Verastem VSTM Stock Holding History

Checkpoint Capital’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-168,739	Closed	-$1.99M	–	21
2024 Q1	$1.99M	Buy	+168,739	New	+$1.95M	1.33%	12

Other funds holding VSTM

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Checkpoint Capital's VSTM Position: Q2 2024 in Review

Checkpoint Capital sold out of Verastem (VSTM) in Q2 2024, closing a stake of 168,739 shares — an estimated $1.99M sold.

Checkpoint Capital first reported a position in VSTM in Q1 2024 and held it in 1 quarter. The position peaked at $1.99M in Q1 2024. 68 funds tracked by Wall St. Rank hold VSTM as of Q2 2024.

Checkpoint Capital reported no remaining Verastem position as of Q2 2024 after selling out during the quarter.
Checkpoint Capital sold 168,739 Verastem shares in Q2 2024, an estimated $1.99M.
Checkpoint Capital first reported a position in Verastem in Q1 2024 and held it in 1 quarter.
Checkpoint Capital's Verastem position peaked at $1.99M in Q1 2024.
68 funds tracked by Wall St. Rank held Verastem as of Q2 2024.

Based on Checkpoint Capital's 13F filing for Q2 2024, filed 14 Aug 2024.